Skip to Content

MD Anderson Events

Ipilimumab in Melanoma

Ipilimumab in Melanoma

  • Review common targeted therapy treatment of metastatic melanoma
  • Identify pathology findings that indicate a patient is a candidate for Ipilimumab
  • Identify patients characteristics that indicate use of Ipilimumab
  • State toxicities Ipilimumab and associated nursing interventions
  • Discuss how Ipilimumab is used in combinations therapies

Date: 4/30/13, 1:30pm to 2:30pm
Time: 4/30/13, 1:30pm to 2:30pm
Location: P10 Conference Room
Format: Training/Employee Development
CME: Contact Hours: 1.0
Speaker: Nydia Gonzalez, FNP
Contact: Cindy Murphy - 39297 - cmurphy@mdanderson.org